About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1NCT06362265

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

The main purpose of this study is to evaluate how much of LY3209590 gets into the blood stream after a single dose and how long it takes the body to remove it in pediatric participants with Type 2 Dia...

Lead sponsor: Eli Lilly and Company•10 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Eli Lilly and Company

Age

10 - 17 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Participants with Type 2 Diabetes Mellitus (T2DM) for at least 3 months
•Have Glycated hemoglobin (HbA1c) level of 6.5 percent (%) to 9.5% at screening
•Have a body mass index equal to or less than 45.0 kilograms per square meter (kg/m²)
•Participants are insulin naïve or have been without insulin treatment for at least 3 months prior to screening

Exclusion Criteria

•Have had a severe hypoglycemia in the past 6 months
•Have a history of renal impairment
•Have had a blood transfusion or severe blood loss within last 90 days
•Have had a significant weight gain or loss of approximately 6% or more within 3 months prior to screening.
•Have a history of an active or untreated malignancy
•Are receiving or received systemic glucocorticoid therapy
•Are currently enrolled in another clinical study trial involving medical research or have participated within the last 30 days in a clinical study involving an investigational product

Related studies

RECRUITINGPhase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT06613854 · Type 2 Diabetes Mellitus (T2DM)

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

NCT06278207 · Chronic Kidney Disease, Type 2 Diabetes Mellitus

Polyphenol Metabotypes in People With Diabetes Type 2

NCT06810635 · Type 2 Diabetes Mellitus (T2DM)

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005 · Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 24, 2026Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment15

Start dateOct 2024

Last updatedMar 24, 2026

Condition

Type 2 Diabetes Mellitus

Locations shown

Children's Hospital Los Angeles

Los Angeles, California

Children's Healthcare of Atlanta - Center for Advanced Pediatrics

Atlanta, Georgia

Centricity Research Columbus Endocrinology

Columbus, Georgia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 24, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions